Government initiatives promoting healthcare innovation and local manufacturing are further bolstering regional growth
Education & Training Degree-Granting Education Postgraduate Training Licenses & Certifications Experience & Service Faculty Academic Appointments Associate Professor, Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, 2017 - 2023 Assistant Professor, Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, 2011 - 2017 Administrative Appointments/Responsibilities Co-Chair, Emil J Freireich Leukemia Hematology Grand Rounds, The University of Texas MD Anderson Cancer Center, Houston, Texas, 2025 - Present Executive Director, Cancer Network, Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, 2022 - Present Director, Cancer Network, Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, 2022 - Present Director, Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN) Program, Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, 2020 - Present Hematology Consultant, Cancer Network, Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, 2019 - 2022 Course Director, Leukemia Rotation, Hematology/Oncology Fellowship Program, Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, 2013 - Present Co-Chair, Leukemia Hematology Grand Rounds, Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, 2012 - 2021 Other Professional Positions Member, Patient Power Advisory Panel, USA, 2021 - 2021 Chief Fellow Housestaff Education, Hematology/Oncology, The University of Texas MD Anderson Cancer Center Fellowship Program, Houston, TX, 2009 - 2010 Extramural Institutional Committee Activities Consultant, Medical Affairs Hematology Steering Committee 2026, Stemline Therapeutics, Inc, 2026 - Present Member, Cancer Communications Committee for the American Society of Clinical Oncology, ASCO, 2026 - 2029 Co-Chair, Scientific Review Committee (SRC) #3, The University of Texas MD Anderson Cancer Center, 2021 - Present Vice Chair, Pharmacy and Therapeutics Committee, The University of Texas MD Anderson Cancer Center, 2021 - Present Member, Clinical Research Committee (CRC), The University of Texas MD Anderson Cancer Center, 2015 - 2021 Member, Pharmacy and Therapeutics Committee, The University of Texas MD Anderson Cancer Center, 2013 - 2021 Member, Clinical Competence Committee, The University of Texas MD Anderson Cancer Center, 2013 - Present Member, Transfusion Committee, The University of Texas MD Anderson Cancer Center, 2013 - 2016 Member, Fellowship Steering Committee, The University of Texas MD Anderson Cancer Center, 2012 - Present Member, OncoLog Editorial Board, The University of Texas MD Anderson Cancer Center, 2012 - 2017 Member, Interviewing Committee, MD Anderson Hematology/Oncology Fellowship Program, The University of Texas MD Anderson Cancer Center, 2010 - Present Editorial Activities Contributing Editor, The Hematologist, 2026 - 2028 Associate Editor, Blood Cancers Today, 2022 - 2023 Editorial Board Member, Journal of Immunotherapy and Precision Oncology (JIPO), 2020 - Present Editorial Board Chair, HemOnc Times, 2018 - 2019 Section Editor, Elsevier, 2016 - Present Advisory Board, Oncology Times, 2016 - 2019 Staff Writer, ASH Daily News, 2016 Honors & Awards Professional Memberships Clinical Lymphoma, Myeloma & Leukemia Editorial Board 2020 - Present Journal of Immunotherapy and Precision Oncology (JIPO) Editorial Board 2020 - 2022 The American Society of Hematology (ASH) Committee on Communications 2020 - 2023 American Soceity of Clinical Oncology (ASCO) Cancer.Net Editorial Board 2020 - 2021 SWOG 2015 - Present Harris County Medical Society 2013 - Present Texas Medical Association 2013 - Present American Association for the Advancement of Science 2012 - Present International CML Foundation 2012 - Present School of Science and Engineering Tulane Health Leaders Alumni Group (THLAG) 2012 - Present Johns Hopkins Medical and Surgical Association 2012 - Present American College of Physicians 2011 - Present American Society for Bone and Mineral Research 2011 - 2015 American Association for Cancer Research 2010 - Present American Society of Clinical Oncology (ASCO) 2009 - Present American Society of Hematology (ASH) 2008 - Present Selected Presentations & Talks Local Presentations 2023
Neither
Research shows both can increase muscle growth and reduce fat in experimental models, with MK 677 increasing IGF-1 levels significantly and Ipamorelin targeting ghrelin receptors to minimize hormonal fluctuations in research subjects
